The FDA has approved a new drug for migraines. In clinical trials, patients who took the drug experienced about two fewer migraines per month compared to placebo. It will cost $575/month, before rebates and discounts.

The FDA has approved a new drug for migraines. In clinical trials, patients who took the drug experienced about two fewer migraines per month compared to placebo. It will cost $575/month, before rebates and discounts.: https://ift.tt/2rXoePF Read more... https://ift.tt/2wM3P5w